title: Conversion to sirolimus in renal transplant recipients with skin cancer.
authors.forename: Chiara Scaglioni
authors.initials: CS
authors.lastname: Tessmer
authors.forename: Luiza Vieira da Silva
authors.initials: LV
authors.lastname: Magalhães
authors.forename: Elizete
authors.initials: E
authors.lastname: Keitel
authors.forename: Cristiana
authors.initials: C
authors.lastname: Valar
authors.forename: Diego
authors.initials: D
authors.lastname: Gnatta
authors.forename: Ronivan Luis Dal
authors.initials: RL
authors.lastname: Pra
authors.forename: Fabiano Roldão
authors.initials: FR
authors.lastname: Silveira
authors.forename: Auri Ferreira
authors.initials: AF
authors.lastname: Dos Santos
authors.forename: João Carlos
authors.initials: JC
authors.lastname: Goldani
authors.forename: Valter Duro
authors.initials: VD
authors.lastname: Garcia
authors.forename: Clotilde Druck
authors.initials: CD
authors.lastname: Garcia
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007668:Kidney / Q000187:drug effects* / Q000502:physiology; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D020123:Sirolimus / Q000008:administration & dosage*; D012878:Skin Neoplasms / Q000517:prevention & control*
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus